AU2003210983A8 - Kinase inhibitors and methods of use thereof - Google Patents
Kinase inhibitors and methods of use thereofInfo
- Publication number
- AU2003210983A8 AU2003210983A8 AU2003210983A AU2003210983A AU2003210983A8 AU 2003210983 A8 AU2003210983 A8 AU 2003210983A8 AU 2003210983 A AU2003210983 A AU 2003210983A AU 2003210983 A AU2003210983 A AU 2003210983A AU 2003210983 A8 AU2003210983 A8 AU 2003210983A8
- Authority
- AU
- Australia
- Prior art keywords
- methods
- kinase inhibitors
- kinase
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35588502P | 2002-02-11 | 2002-02-11 | |
US60/355,885 | 2002-02-11 | ||
PCT/US2003/004163 WO2003068157A2 (en) | 2002-02-11 | 2003-02-11 | Kinase inhibitors and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003210983A1 AU2003210983A1 (en) | 2003-09-04 |
AU2003210983A8 true AU2003210983A8 (en) | 2003-09-04 |
Family
ID=27734578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003210983A Abandoned AU2003210983A1 (en) | 2002-02-11 | 2003-02-11 | Kinase inhibitors and methods of use thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003210983A1 (en) |
WO (1) | WO2003068157A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4751336B2 (en) | 2003-12-11 | 2011-08-17 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | Compound for treating cell proliferative disorders |
US20100292229A1 (en) * | 2006-06-30 | 2010-11-18 | The Board Of Regents Of The University Of Texas System | Tryphostin-analogs for the treatment of cell proliferative diseases |
EP2307367B1 (en) | 2008-07-08 | 2014-09-24 | Board of Regents, The University of Texas System | Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
EP2688890B1 (en) | 2011-03-22 | 2017-08-30 | Advinus Therapeutics Limited | Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
HUE033019T2 (en) * | 2011-05-17 | 2017-11-28 | Principia Biopharma Inc | Tyrosine kinase inhibitors |
PT2892900T (en) | 2012-09-10 | 2017-11-06 | Principia Biopharma Inc | Pyrazolopyrimidine compounds as kinase inhibitors |
US9593115B2 (en) | 2012-09-21 | 2017-03-14 | Advinus Therapeutics Ltd. | Substituted fused tricyclic compounds, compositions, and medicinal applications thereof |
EP3107544B1 (en) | 2014-02-21 | 2020-10-07 | Principia Biopharma Inc. | Salts and solid form of a btk inhibitor |
CA2948883A1 (en) * | 2014-06-02 | 2015-12-10 | Pharmakea, Inc. | Deubiquitinase inhibitors |
CA2970723C (en) | 2014-12-18 | 2023-09-05 | Principia Biopharma Inc. | Treatment of pemphigus |
TW201718572A (en) | 2015-06-24 | 2017-06-01 | 普林斯匹亞生物製藥公司 | Tyrosine kinase inhibitors |
EP3478273A1 (en) | 2016-06-29 | 2019-05-08 | Principia Biopharma Inc. | Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile |
TW201922707A (en) | 2017-11-10 | 2019-06-16 | 美國德州系統大學評議委員會 | Caffeic acid derivatives and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5854285A (en) * | 1997-04-03 | 1998-12-29 | Natpro, Inc. | Protein kinase inhibitor |
CA2265396A1 (en) * | 1999-03-12 | 2000-09-12 | Chaim M. Roifman | Methods and compositions for treating leukemia |
-
2003
- 2003-02-11 WO PCT/US2003/004163 patent/WO2003068157A2/en not_active Application Discontinuation
- 2003-02-11 AU AU2003210983A patent/AU2003210983A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003210983A1 (en) | 2003-09-04 |
WO2003068157A2 (en) | 2003-08-21 |
WO2003068157A3 (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003303128A8 (en) | Inhibitors and methods of use thereof | |
TWI346663B (en) | P38 inhibitors and methods of use thereof | |
EP1606283A4 (en) | P38 inhibitors and methods of use thereof | |
EP1601357A4 (en) | Heterocyclic kinase inhibitors: methods of use and synthesis | |
EP1507756A4 (en) | Ccr9 inhibitors and methods of use thereof | |
AU2003217870A8 (en) | Pini-modulating compounds and methods of use thereof | |
PL375447A1 (en) | Protein kinase inhibitors and uses thereof | |
IL173936A0 (en) | Heterocyclic inhibitors of mek and methods of use thereof | |
EP1465615A4 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
AU2003213673A8 (en) | Pin1-modulating compounds and methods of use thereof | |
EP1534680A4 (en) | Prenylation inhibitors and methods of their synthesis and use | |
HK1160859A1 (en) | Inhibitors of tyrosine kinases | |
HK1072545A1 (en) | Novel inhibitors of kinases | |
PL376789A1 (en) | Aminoindazole derivatives and use thereof as kinase inhibitors | |
EP1448218A4 (en) | Beta-secretase inhibitors and methods of use | |
EP1691812A4 (en) | Gtpase inhibitors and methods of use | |
AU2003220437A1 (en) | Thiopyrimidine and isothiazolopyrimidine kinase inhibitors | |
AU2003210983A8 (en) | Kinase inhibitors and methods of use thereof | |
PL374581A1 (en) | Diaminothiazoles and use thereof as cdk4 inhibitors | |
AU2002337913A1 (en) | Glycosulfopeptide inhibitors and methods of use thereof | |
AU2003299815A1 (en) | Matriptase inhibitors and methods of use | |
EP1682115A4 (en) | Hif-1 inhibitors and methods of use thereof | |
EP1545287A4 (en) | Vasoregulating compounds and methods of their use | |
AU2003238948A8 (en) | Caspase-1 inhibitors and methods for their use | |
ZA200500492B (en) | Novel inhibitors of kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |